STAN as an adjunct to intrapartum fetal heart rate monitoring did not improve perinatal outcomes

In a study to be presented on Feb. 5 in an oral plenary session at 8 a.m. PST, at the Society for Maternal-Fetal Medicine’s annual meeting, The Pregnancy Meeting, in San Diego, researchers will report that use of the ST segment as an adjunct to conventional intrapartum electronic fetal heart rate monitoring did not improve perinatal outcomes or decrease operative deliveries in hospitals in the United States. STAN is used in Europe as an adjunct to conventional intrapartum fetal heart rate monitoring, and was approved by the FDA for use in the US, mostly based on results of studies in Europe and one small study in the US. —> Read More Here

facebooktwittergoogle_plusredditpinterestlinkedinmail

Leave a Reply

Your email address will not be published. Required fields are marked *